Description
| Item ID # | 57118900 |
| Manufacturer # | 58160082111 |
| Brand | ENGERIX-B® |
Features
- Preservative free
- It is supplied as a sterile suspension for intramuscular administration
- It is ready for use without reconstitution
ENGERIX-B® Hepatitis B Vaccine Adult 20 mcg / mL Injection Single Dose Vial 1 mL
UOM PACK/10
$807.70
Features
- Preservative free
- It is supplied as a sterile suspension for intramuscular administration
- It is ready for use without reconstitution
10000 in stock
Related products
-
#47768900 Mfr# 2434892Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 30 Vials
Item ID # 47768900 Manufacturer # 2434892 Brand -
#58198900 Mfr#Fluarix® Quadrivalent Flu Vaccine 60 mcg / 0.5 mL Users 3 Years and Older Prefilled Syringe 0.5 mL
Features
- FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- FLUARIX QUADRIVALENT is approved for use in persons 3 years of age and older
-
#58908900 Mfr# 589-05Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
-
#58908900 Mfr#
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart